HSPA5 and neoplasm: The vector was intended for intravenous administration, and its dual tumor targeting system relied on, firstly, targeting αvβ3 integrin receptor by phage-expressed ligand RGD4C, and secondly, tumor-specific and temozolomide-induced gene expression from a Grp78 promotor, acting as suicide gene therapy.